CAS 1855871-76-9

Formula: C34H38N2O4

InChI: InChI=1S/C34H38N2O4/c1-25-9-7-11-27(19-25)23-39-32-15-5-3-13-29(32)21-36(18-17-31(35)34(37)38)22-30-14-4-6-16-33(30)40-24-28-12-8-10-26(2)20-28/h3-16,19-20,31H,17-18,21-24,35H2,1-2H3,(H,37,38)/t31-/m0/s1

InChI key: YGKNVAAMULVFNN-HKBQPEDESA-N

SMILES: CC1=CC(=CC=C1)COC2=CC=CC=C2CN(CC[C@@H](C(=O)O)N)CC3=CC=CC=C3OCC4=CC=CC(=C4)C

(S)-2-Amino-4-(bis(2-((3-methylbenzyl)oxy)benzyl)amino)butanoic acid

CAS: 1855871-76-9

Formula: C₃₄H₃₈N₂O₄

Purity: 99%

Color and Shape: Solid

Molecular weight: 538.6765

Ref: IN-DA01LIRW

V-9302

CAS: 1855871-76-9

V-9302

Formula: C₃₄H₃₈N₂O₄

Purity: ≥98%

Molecular weight: 538.68

Ref: 54-BUP06141

V-9302

CAS: 1855871-76-9

(S)-2-Amino-4-(bis(2-((3-methylbenzyl)oxy)benzyl)amino)butanoic acid

Formula: C₃₄H₃₈N₂O₄

Purity: 99%

Molecular weight: 538.68

Ref: IN-DG00969213

(2S)-2-amino-4-[bis[[2-[(3-methylphenyl)methoxy]phenyl]methyl]amino]-butanoic acid

CAS: 1855871-76-9

Purity: 99%

Molecular weight: 538.688

Ref: 10-F980878

V-9302

CAS: 1855871-76-9

V-9302 is a drug that inhibits the growth of cancer cells. It is a member of the sorafenib family and acts as an inhibitor of fatty acid synthase (FAS) and Vaspin, which are pro-apoptotic proteins. V-9302 has been shown to inhibit protein synthesis in vitro by binding to ribosomes, and also binds to various proteins in colorectal adenocarcinoma cells. V-9302 has shown efficacy against myeloid leukemia cell lines in vitro, but not against fetal bovine or normal human erythrocytes.

Formula: C₃₄H₃₈N₂O₄

Purity: Min. 95%

Molecular weight: 538.68 g/mol

Ref: 3D-FZC87176

V-9302

CAS: 1855871-76-9

V-9302 (V9302) is a competitive antagonist of transmembrane glutamine flux that selectively and potently targets the amino acid transporter ASCT2 (IC50: 9.6 uM

Formula: C₃₄H₃₈N₂O₄

Purity: 98% - 99.54%

Color and Shape: Solid

Molecular weight: 538.68

Ref: TM-T5345